Vanguard Group Inc Kymera Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,753,766 shares of KYMR stock, worth $227 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,753,766

Previous 4,822,416 1.42%

Holding current value

$227 Million

Previous $144 Million 56.3%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$30.16 - $52.4 $2.07 Million - $3.6 Million	-68,650 Reduced 1.42%	4,753,766 $225 Million
Q2 2024 Aug 13, 2024	BUY	$29.85 - $39.42 $1.65 Million - $2.18 Million	55,366 Added 1.16%	4,822,416 $144 Million
Q1 2024 May 10, 2024	BUY	$22.9 - $43.57 $17.6 Million - $33.5 Million	769,486 Added 19.25%	4,767,050 $192 Million
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $793,690 - $1.94 Million	72,351 Added 1.84%	3,997,564 $102 Million
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $2.53 Million - $4.35 Million	182,125 Added 4.87%	3,925,213 $54.6 Million
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $205,251 - $319,971	9,163 Added 0.25%	3,743,088 $86.1 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $1.83 Million - $2.85 Million	73,618 Added 2.01%	3,733,925 $111 Million
Q4 2022 Feb 10, 2023	BUY	$19.57 - $30.92 $15.6 Million - $24.6 Million	797,130 Added 27.84%	3,660,307 $91.4 Million
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $241,447 - $395,715	-11,547 Reduced 0.4%	2,863,177 $62.3 Million
Q2 2022 Aug 12, 2022	BUY	$14.13 - $42.55 $522,795 - $1.57 Million	36,999 Added 1.3%	2,874,724 $56.6 Million
Q1 2022 May 13, 2022	SELL	$35.3 - $64.68 $4.22 Million - $7.73 Million	-119,449 Reduced 4.04%	2,837,725 $120 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $2.77 Million - $3.65 Million	55,600 Added 1.92%	2,957,174 $188 Million
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $41 Million - $57.2 Million	857,350 Added 41.94%	2,901,574 $170 Million
Q2 2021 Aug 13, 2021	BUY	$31.08 - $51.95 $63.5 Million - $106 Million	2,044,224 New	2,044,224 $99.1 Million

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.61B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Kymera Therapeutics, Inc. Transaction History